Given the complexity of topoisomerases and DNA repair pathways, it may be that a multifactorial approach, rather than reliance on a single biomarker, is needed to identify anthracycline-sensitive patients
Predictive molecular markers of anthracycline effectiveness in early breast cancer / Di Leo A; Moretti E; Oakman C; Biganzoli L; Santarpia L. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - ELETTRONICO. - (2011), pp. 16-21.
Predictive molecular markers of anthracycline effectiveness in early breast cancer
MORETTI, ERICA;
2011
Abstract
Given the complexity of topoisomerases and DNA repair pathways, it may be that a multifactorial approach, rather than reliance on a single biomarker, is needed to identify anthracycline-sensitive patients
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
